Monthly Archives: June, 2023

Browse our exclusive articles!

OpenAI CEO Sam Altman Finally Watches Ex Machina – A Film About a Tech Billionaire Who Creates Dangerous AI.

OpenAI CEO Sam Altman tweets about the possible risks posed by AI after watching 2015 film Ex Machina. Some Twitter users respond with insights on AI performance and evaluation.

Eating Disorder Chatbot Disabled Over Accusations of Harm

NEDA faces criticism for replacing help-line staff with Tessa, a chatbot developed by Cass. Concerns heightened over harmful advice & devaluing human interaction.

3 AI Stocks with Potential to Multiply Your Investment by 10x in a Decade

Discover three AI stocks with tremendous growth potential for risk-tolerant investors. Explore Upstart Holdings, C3.ai, and Micron Technology today.

Kdan Mobile and CyberLink Join Forces to Boost e-Signature Anti-Fraud Features with AI Technology

Kdan Mobile collaborates with CyberLink to amplify e-signature anti-fraud capabilities with AI. The integration of DottedSign and FaceMe enhances the identification abilities of the e-signature process. It sets a new milestone for Kdan and potential future partnerships.

Innovative AI Technology Boosts Florida’s Real Estate Market

Listing3D launches PropertyPulse.AI - an AI-driven platform for FairLeadRealty to assist real estate professionals in the low-inventory market.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img